WASHINGTON (Reuters) – Initial deliveries of the newly approved Johnson & Johnson (NYSE:) COVID-19 vaccine should start on Tuesday, helping to boost vaccination rates across the country, senior administration officials said on Sunday.
The officials acknowledged that vaccination rates among minorities were “not where we ultimately want them to be”, but said federal officials were closely monitoring distribution to ensure it was equitable.
They urged everyone in the United States to get a vaccination as soon as it was their turn, and said Black and brown Americans should understand that safeguards had been put in place after past cases of discrimination in the medical field.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Be the first to comment